The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Doxorubicin loaded iron oxide nanoparticles overcome multidrug resistance in cancer in vitro
Open accessAbstract
Multidrug resistance (MDR) is characterized by the overexpression of ATP-binding cassette (ABC) transporters that actively pump a broad class of hydrophobic chemotherapeutic drugs out of cancer cells. MDR is a major mechanism of treatment resistance in a variety of human tumors, and clinically applicable strategies to circumvent MDR remain to be characterized. Here we describe the fabrication and characterization of a drug-loaded iron oxide nanoparticle designed to circumvent MDR. Doxorubicin (DOX), an anthracycline antibiotic commonly used in cancer chemotherapy and substrate for ABC-mediated drug efflux, was covalently bound to polyethylenimine via a pH sensitive hydrazone linkage and conjugated to an iron oxide nanoparticle coated with amine terminated polyethylene glycol. Drug loading, physiochemical properties and pH lability of the DOX-hydrazone linkage were evaluated in vitro. Nanoparticle uptake, retention, and dose-dependent effects on viability were compared in wild-type and DOX-resistant ABC transporter over-expressing rat glioma C6 cells. We found that DOX release from nanoparticles was greatest at acidic pH, indicative of cleavage of the hydrazone linkage. DOX-conjugated nanoparticles were readily taken up by wild-type and drug-resistant cells. In contrast to free drug, DOX-conjugated nanoparticles persisted in drug-resistant cells, indicating that they were not subject to drug efflux. Greater retention of DOX-conjugated nanoparticles was accompanied by reduction of viability relative to cells treated with free drug. Our results suggest that DOX-conjugated nanoparticles could improve the efficacy of chemotherapy by circumventing MDR.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Boussif, O., Lezoualc'h, F., Zanta, M. A., Mergny, M. D., Scherman, D., Demeneix, B., & Behr, J. P. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.16.7297 · Cited by 6,247
Multidrug resistance in cancer: role of ATP–dependent transporters
Gottesman, M. M., Fojo, T., & Bates, S. E. (2002) · Nature Reviews Cancer · doi:10.1038/nrc706 · Cited by 5,536
Nanoparticle therapeutics: an emerging treatment modality for cancer
Davis, M. E., Chen, Z., & Shin, D. M. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2614 · Cited by 4,233
Factors affecting the clearance and biodistribution of polymeric nanoparticles
Alexis, F., Pridgen, E., Molnar, L. K., & Farokhzad, O. C. (2008) · Molecular Pharmaceutics · doi:10.1021/mp800051m · Cited by 3,699
Targeting multidrug resistance in cancer
Szakács, G., Paterson, J. K., Ludwig, J. A., Booth-Genthe, C., & Gottesman, M. M. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd1984 · Cited by 3,609
Magnetic nanoparticles in MR imaging and drug delivery
Sun, C., Lee, J. S. H., & Zhang, M. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.03.018 · Cited by 2,594
Self-citationLongmire, M., Choyke, P. L., & Kobayashi, H. (2008) · Nanomedicine · doi:10.2217/17435889.3.5.703 · Cited by 2,149
Design and fabrication of magnetic nanoparticles for targeted drug delivery and imaging
Veiseh, O., Gunn, J. W., & Zhang, M. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.11.002 · Cited by 1,832
Self-citationMagnetic nanoparticles for drug delivery
Arruebo, M., Fernández-Pacheco, R., Ibarra, M. R., & Santamaría, J. (2007) · Nano Today · doi:10.1016/s1748-0132(07)70084-1 · Cited by 1,613
Liposomes and nanoparticles: nanosized vehicles for drug delivery in cancer
Malam, Y., Loizidou, M., & Seifalian, A. M. (2009) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2009.08.004 · Cited by 1,318
Fischer, D., Bieber, T., Li, Y., Elsässer, H.-P., & Kissel, T. (1999) · Pharmaceutical Research · doi:10.1023/a:1014861900478 · Cited by 1,217
Superparamagnetic iron oxide: pharmacokinetics and toxicity
Weissleder, R., Stark, D., Engelstad, B., Bacon, B., Compton, C., White, D., Jacobs, P., & Lewis, J. (1989) · American Journal of Roentgenology · doi:10.2214/ajr.152.1.167 · Cited by 1,045
Magnetic nanoparticles for theragnostics
Shubayev, V. I., Pisanic, T. R., & Jin, S. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.03.007 · Cited by 1,028
ABC transporters in cancer: more than just drug efflux pumps
Fletcher, J. I., Haber, M., Henderson, M. J., & Norris, M. D. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2789 · Cited by 1,018
Iron Oxide Nanoparticles for Sustained Delivery of Anticancer Agents
Jain, T. K., Morales, M. A., Sahoo, S. K., Leslie-Pelecky, D. L., & Labhasetwar, V. (2005) · Molecular Pharmaceutics · doi:10.1021/mp0500014 · Cited by 904
Bartlett, D. W., Su, H., Hildebrandt, I. J., Weber, W. A., & Davis, M. E. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707461104 · Cited by 803
Mechanism of active targeting in solid tumors with transferrin-containing gold nanoparticles
Choi, C. H. J., Alabi, C. A., Webster, P., & Davis, M. E. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914140107 · Cited by 699
Yu, M. K., Jeong, Y. Y., Park, J., Park, S., Kim, J. W., Min, J. J., Kim, K., & Jon, S. (2008) · Angewandte Chemie International Edition · doi:10.1002/anie.200800857 · Cited by 615
Kohler, N., Sun, C., Wang, J., & Zhang, M. (2005) · Langmuir · doi:10.1021/la0503451 · Cited by 579
Self-citationDoxorubicin loaded pH-sensitive polymeric micelles for reversal of resistant MCF-7 tumor
Lee, E. S., Na, K., & Bae, Y. H. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.12.018 · Cited by 577
Tuning payload delivery in tumour cylindroids using gold nanoparticles
Kim, B., Han, G., Toley, B. J., Kim, C.-K., Rotello, V. M., & Forbes, N. S. (2010) · Nature Nanotechnology · doi:10.1038/nnano.2010.58 · Cited by 479
Kohler, N., Sun, C., Fichtenholtz, A., Gunn, J., Fang, C., & Zhang, M. (2006) · Small · doi:10.1002/smll.200600009 · Cited by 424
Self-citationMulti-functional nanocarriers to overcome tumor drug resistance
Jabr-Milane, L. S., van Vlerken, L. E., Yadav, S., & Amiji, M. M. (2008) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2008.04.003 · Cited by 407
Nanotheranostics and image-guided drug delivery: current concepts and future directions
Lammers, T., Kiessling, F., Hennink, W. E., & Storm, G. (2010) · Molecular Pharmaceutics · doi:10.1021/mp100228v · Cited by 397
Pharmacological Strategies for Overcoming Multidrug Resistance
Nobili, S., Landini, I., Giglioni, B., & Mini, E. (2006) · Current Drug Targets · doi:10.2174/138945006777709593 · Cited by 393
Lyass, O., Uziely, B., Ben-Yosef, R., Tzemach, D., Heshing, N. I., Lotem, M., Brufman, G., & Gabizon, A. (2000) · Cancer · doi:10.1002/1097-0142(20000901)89:5<1037::aid-cncr13>3.0.co;2-z · Cited by 385
Aldo-Keto Reductases and Bioactivation/Detoxication
Jin, Y., & Penning, T. M. (2007) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.47.120505.105337 · Cited by 383
Kievit, F. M., Veiseh, O., Bhattarai, N., Fang, C., Gunn, J. W., Lee, D., Ellenbogen, R. G., Olson, J. M., & Zhang, M. (2009) · Advanced Functional Materials · doi:10.1002/adfm.200801844 · Cited by 381
Self-citationTargeting cancer cells: magnetic nanoparticles as drug carriers
Alexiou, C., Schmid, R. J., Jurgons, R., Kremer, M., Wanner, G., Bergemann, C., Huenges, E., Nawroth, T., Arnold, W., & Parak, F. G. (2006) · European Biophysics Journal · doi:10.1007/s00249-006-0042-1 · Cited by 362
Maeng, J. H., Lee, D.-H., Jung, K. H., Bae, Y.-H., Park, I.-S., Jeong, S., Jeon, Y.-S., Shim, C.-K., Kim, W., Kim, J., et al. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.02.068 · Cited by 333
A Nanoparticle Size Series for In Vivo Fluorescence Imaging
Popović, Z., Liu, W., Chauhan, V. P., Lee, J., Wong, C., Greytak, A. B., Insin, N., Nocera, D. G., Fukumura, D., Jain, R. K., et al. (2010) · Angewandte Chemie International Edition · doi:10.1002/anie.201003142 · Cited by 332
Yang, J., Lee, C., Ko, H., Suh, J., Yoon, H., Lee, K., Huh, Y., & Haam, S. (2007) · Angewandte Chemie International Edition · doi:10.1002/anie.200703554 · Cited by 331
Nanomedicinal Strategies to Treat Multidrug-Resistant Tumors: Current Progress
Dong, X., & Mumper, R. J. (2010) · Nanomedicine · doi:10.2217/nnm.10.35 · Cited by 317
Remotely Triggered Release from Magnetic Nanoparticles
Derfus, A. M., von Maltzahn, G., Harris, T. J., Duza, T., Vecchio, K. S., Ruoslahti, E., & Bhatia, S. N. (2007) · Advanced Materials · doi:10.1002/adma.200700091 · Cited by 282
Sun, C., Du, K., Fang, C., Bhattarai, N., Veiseh, O., Kievit, F., Stephen, Z., Lee, D., Ellenbogen, R. G., Ratner, B., et al. (2010) · ACS Nano · doi:10.1021/nn100190v · Cited by 271
Self-citationShen, F., Chu, S., Bence, A. K., Bailey, B., Xue, X., Erickson, P. A., Montrose, M. H., Beck, W. T., & Erickson, L. C. (2008) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.127704 · Cited by 263
Functionalized Nanoparticles with Long‐Term Stability in Biological Media
Fang, C., Bhattarai, N., Sun, C., & Zhang, M. (2009) · Small · doi:10.1002/smll.200801647 · Cited by 259
Self-citationChlorotoxin Labeled Magnetic Nanovectors for Targeted Gene Delivery to Glioma
Kievit, F. M., Veiseh, O., Fang, C., Bhattarai, N., Lee, D., Ellenbogen, R. G., & Zhang, M. (2010) · ACS Nano · doi:10.1021/nn1008512 · Cited by 222
Self-citationGarcion, E., Lamprecht, A., Heurtault, B., Paillard, A., Aubert-Pouessel, A., Denizot, B., Menei, P., & Benoît, J.-P. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0289 · Cited by 198
Xiong, X.-B., Ma, Z., Lai, R., & Lavasanifar, A. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2009.09.080 · Cited by 193
Cardiotoxicity of Antitumor Drugs
Menna, P., Salvatorelli, E., & Minotti, G. (2008) · Chemical Research in Toxicology · doi:10.1021/tx800002r · Cited by 163
Nanoparticle-based theragnostics: Integrating diagnostic and therapeutic potentials in nanomedicine
Fang, C., & Zhang, M. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.05.013 · Cited by 138
Self-citationA ligand-mediated nanovector for targeted gene delivery and transfection in cancer cells
Omid Veiseh, A., Kievit, F. M., Gunn, J., Ratner, B. D., & Zhang, M. (2008) · Biomaterials · doi:10.1016/j.biomaterials.2008.10.003 · Cited by 130
Self-citationNovel drug release profiles from micellar solutions of PLA–PEO–PLA triblock copolymers
Agrawal, S. K., Sanabria-DeLong, N., Coburn, J. M., Tew, G. N., & Bhatia, S. R. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.12.024 · Cited by 115
Rekha, M. R., & Sharma, C. P. (2010) · Acta Biomaterialia · doi:10.1016/j.actbio.2010.07.027 · Cited by 99
The application of Fe3O4 nanoparticles in cancer research: A new strategy to inhibit drug resistance
Wang, X., Zhang, R., Wu, C., Dai, Y.-Y., Song, M., Gutmann, S., Gao, F., Lv, G., Li, J., Li, X., et al. (2006) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.30901 · Cited by 95
Promotion of glioma cell survival by acyl-CoA synthetase 5 under extracellular acidosis conditions
Mashima, T., Sato, S., Sugimoto, Y., Tsuruo, T., & Seimiya, H. (2009) · Oncogene · doi:10.1038/onc.2008.355 · Cited by 78
Guo, M., Yu, Y., Liu, X., Yan, H., Liu, K., Zhang, H., & Cao, Y. (2009) · Nanoscale · doi:10.1039/b9nr00244h · Cited by 68
Kim, H., Kim, H. A., Bae, Y. M., Choi, J. S., & Lee, M. (2009) · The Journal of Gene Medicine · doi:10.1002/jgm.1320 · Cited by 46
Chen, B. (2009) · International Journal of Nanomedicine · doi:10.2147/ijn.s5093 · Cited by 33
Lai, J.-R., Chang, Y., Yen, H., Yuan, N.-Y., Liao, M., Hsu, C., Tsai, J.-L., & Lai, P. (2010) · Journal of Applied Physics · doi:10.1063/1.3357344 · Cited by 27
The effect of pendant hydrophobicity on the biological efficacy of polyethylenimine conjugate
Su, L., Fang, T., & Tseng, W. (2009) · Biochemical Engineering Journal · doi:10.1016/j.bej.2009.11.006 · Cited by 9
Cited by
Ulbrich, K., Holá, K., Šubr, V., Bakandritsos, A., Tuček, J., & Zbořil, R. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00589 · Cited by 1,730
Superparamagnetic iron oxide nanoparticles: magnetic nanoplatforms as drug carriers
Wahajuddin, & Arora (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s30320 · Cited by 1,117
Surface-Engineered Magnetic Nanoparticle Platforms for Cancer Imaging and Therapy
Xie, J., Liu, G., Eden, H. S., Ai, H., & Chen, X. (2011) · Accounts of Chemical Research · doi:10.1021/ar200044b · Cited by 582
Applications and potential toxicity of magnetic iron oxide nanoparticles
Liu, G., Gao, J., Ai, H., & Chen, X. (2013) · Small · doi:10.1002/smll.201201531 · Cited by 570
Magnetic iron oxide nanoparticles for drug delivery: applications and characteristics
Vangijzegem, T., Stanicki, D., & Laurent, S. (2019) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2019.1554647 · Cited by 548
Metadata
- Authors
- Kievit, F. M., Wang, F. Y., Fang, C., Mok, H., Wang, K., Silber, J. R., Ellenbogen, R. G., & Zhang, M.
- Venue
- Journal of Controlled Release
- Publisher
- Elsevier BV
- Published
- 2011-05
- Volume
- 152
- Issue
- 1
- Pages
- 76-83
- ISSN
- 0168-3659 (ISSN-L)
- OpenAlex
- W2082754759
- Cited by
- 289
- References
- 52
- FWCI
- 10.25
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.